Total Payments
$55,540
2024 Payments
$2,375
Companies
6
Transactions
73
Medicare Patients
1,464
Medicare Billing
$178,119
Payment Breakdown by Category
Consulting$54,178 (97.5%)
Travel$902.94 (1.6%)
Food & Beverage$373.74 (0.7%)
Education$85.00 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $54,178 | 66 | 97.5% |
| Travel and Lodging | $902.94 | 2 | 1.6% |
| Food and Beverage | $373.74 | 4 | 0.7% |
| Education | $85.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $45,728 | 62 | $0 (2024) |
| Janssen Biotech, Inc. | $5,107 | 5 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $2,120 | 2 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $1,400 | 2 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $1,100 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $85.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,375 | 6 | PFIZER INC. ($2,375) |
| 2023 | $2,675 | 8 | PFIZER INC. ($2,675) |
| 2022 | $5,205 | 11 | PFIZER INC. ($4,105) |
| 2021 | $1,200 | 2 | PFIZER INC. ($1,200) |
| 2020 | $6,605 | 10 | PFIZER INC. ($6,605) |
| 2019 | $14,308 | 14 | PFIZER INC. ($12,908) |
| 2018 | $15,945 | 15 | PFIZER INC. ($15,860) |
| 2017 | $7,227 | 7 | Janssen Biotech, Inc. ($5,107) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/22/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 06/14/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 06/04/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 04/01/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| 03/14/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 01/30/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| 11/28/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| 10/18/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 07/28/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| 06/30/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| 05/30/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 04/28/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 03/30/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 02/28/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 12/21/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| 12/07/2022 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 11/16/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 10/20/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $190.00 | General |
| 09/13/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $140.00 | General |
| 08/09/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| 07/05/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| 06/03/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 04/20/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $215.00 | General |
| 03/15/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| 01/12/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $810.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 160 | 282 | $76,488 | $18,055 |
| 2022 | 7 | 391 | 729 | $226,759 | $53,421 |
| 2021 | 9 | 503 | 899 | $259,270 | $65,516 |
| 2020 | 8 | 410 | 716 | $140,213 | $41,127 |
Total Patients
1,464
Total Services
2,626
Medicare Billing
$178,119
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 71 | 157 | $51,182 | $11,549 | 22.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 31 | $7,223 | $2,055 | 28.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 28 | 40 | $6,760 | $1,902 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $5,798 | $1,256 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 15 | $3,315 | $671.16 | 20.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 21 | 26 | $2,210 | $621.81 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 209 | 477 | $155,502 | $35,521 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 35 | 40 | $18,899 | $4,785 | 25.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 68 | 97 | $16,393 | $4,305 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 18 | 18 | $10,908 | $2,819 | 25.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 45 | $10,485 | $2,752 | 26.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $6,174 | $1,621 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 33 | 38 | $8,398 | $1,618 | 19.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 199 | 481 | $155,948 | $38,937 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 97 | 127 | $28,015 | $6,309 | 22.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 69 | 98 | $16,562 | $4,610 | 27.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 32 | $15,279 | $3,897 | 25.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 22 | 22 | $13,332 | $3,599 | 27.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 50 | $11,670 | $3,150 | 27.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 21 | $9,359 | $2,503 | 26.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 42 | 49 | $4,165 | $1,273 | 30.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 18 | 19 | $4,940 | $1,238 | 25.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 176 | 413 | $78,987 | $24,355 | 30.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 88 | 108 | $17,484 | $4,607 | 26.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 50 | $11,900 | $3,169 | 26.6% |
About Dr. Glenn Bubley, MD
Dr. Glenn Bubley, MD is a Hematology & Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881614485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Bubley, MD has received a total of $55,540 in payments from pharmaceutical and medical device companies, with $2,375 received in 2024. These payments were reported across 73 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($54,178).
As a Medicare-enrolled provider, Bubley has provided services to 1,464 Medicare beneficiaries, totaling 2,626 services with total Medicare billing of $178,119. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Boston, MA
- Active Since 07/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1881614485
Products in Payments
- ZYTIGA (Drug) $5,107
- Xofigo (Drug) $2,120
- PROVENGE (Drug) $1,400
- ERLEADA (Drug) $1,100
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boston
Dr. Julio Hajdenberg, Md, MD
Hematology & Oncology — Payments: $1.1M
Hematology & Oncology $1.1M
Dr. Eric Jacobsen, Md, MD
Hematology & Oncology — Payments: $1.1M
Hematology & Oncology $1.1M
Paul Richardson, Md, MD
Hematology & Oncology — Payments: $920,265
Hematology & Oncology $920,265
Matthew Davids, M.d, M.D
Hematology & Oncology — Payments: $808,362
Hematology & Oncology $808,362
David Avigan, M.d, M.D
Hematology & Oncology — Payments: $679,225
Hematology & Oncology $679,225
Anthony Letai, Md, MD
Hematology & Oncology — Payments: $569,795
Hematology & Oncology $569,795